Sellas Life Sciences Group(SLS)
NEW YORK, NY
BiotechnologyFocus: Cancer Immunotherapies
Sellas Life Sciences Group is a life sciences company focused on Cancer Immunotherapies.
Oncology
Funding Stage
PUBLIC
Open Jobs
0
Pipeline & Clinical Trials
Galinpepimut-S
Acute Myeloid LeukemiaClinical Trials (1)
NCT05593185Expanded Access Program (EAP) for Galinpepimut-S (GPS) in Patients Diagnosed With AML or MDS
N/ASLS009
Hematologic MalignanciesClinical Trials (1)
NCT04588922Study of SLS009 (Formerly GFH009) a Potent Highly Selective CDK9 Inhibitor in Patients With Hematologic Malignancies
Phase 1/2galinpepimut-S
Acute Myelogenous LeukemiaGalinpepimut-S
Multiple MyelomaClinical Trials (1)
NCT01827137WT1 Vaccine Treatment of Patients With Multiple Myeloma After Autologous Stem Cell Transplantation
Phase 1/2Galinpepimut-S + Montanide + GM-CSF
Malignant Pleural MesotheliomaClinical Trials (1)
NCT01265433Galinpepimut-S (WT-1 Analog Peptide) Vaccine in Malignant Pleural Mesothelioma After Combined Modality Therapy
Phase 2NeuVax vaccine
Breast CancerGalinpepimut-S
Acute Myeloid LeukemiaClinical Trials (1)
NCT01266083WT1 Vaccine Treatment of Patients in Remission From Acute Myeloid Leukemia (AML) or Acute Lymphoblastic Leukemia (ALL)
Phase 2Herceptin
Breast CancerGalinpepimut-S
Acute Myeloid LeukemiaClinical Trials (1)
NCT04229979Galinpepimut-S Versus Investigator's Choice of Best Available Therapy for Maintenance in AML CR2/CRp2
Phase 3Open Jobs (0)
No open positions listed yet. Check their careers page directly.
Interview Prep Quick Facts
Founded: 2010
Portfolio: 6 clinical trials
Top TAs: Oncology
SEC Filings: 2 available
Hiring Trend
Stable
0
Open Roles
+0
Added
-0
Filled/Removed
Based on last 4 crawl cycles